Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesNatriuretic peptides in systemic sclerosis-related pulmonary arterial hypertension
Seminars in Arthritis and Rheumatism, 06/23/09
Dimitroulas T et al. – Study concludes that systemic sclerosis (SSc) patients, particularly those with pulmonary arterial hypertension (PAH), have a derangement of the neurohormonal system, which worsens with disease severity and disease progression. Natriuretic peptides (NP) seem to be suitable noninvasive biomarkers for SSc PAH patients in terms of screening, diagnostic evaluation, risk stratification, and response to therapy, and this merits prospective evaluation.
Methods- Review to examine the evidence for the physiologic, diagnostic, and prognostic role of NP in the context of SSc PAH
- Medline search for articles published between Jan 1999 and Dec 2008
- Keywords: natriuretic peptides, systemic sclerosis or scleroderma, and pulmonary arterial hypertension
- In pts with SSc PAH, NP levels increase in proportion to the extent of right ventricular dysfunction
- They correlate significantly with functional capacity and echocardiographic and hemodynamic parameters
- NP may also provide prognostic information beyond conventional risk markers
- However, their use has to be considered against the background of the parameters that may influence their concentration
Related Articles
Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09
Relevance Score: 89%
Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis
Internal Medicine Journal, 10/21/09
Relevance Score: 88%
Is pulmonary arterial hypertension really a late complication of systemic sclerosis
Chest, 10/12/09
Relevance Score: 86%
New finding could lead to cure of pulmonary arterial hypertension
Internet Source, 10/26/09
Relevance Score: 82%
Inhibitory Effects of Simvastatin on Platelet-derived Growth Factor Signaling in Pulmonary Artery Smooth Muscle Cells from Patients with Idiopathic Pulmonary Arterial Hypertension
Journal of Cardiovascular Pharmacology, 10/12/09
Relevance Score: 81%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Absence or Inhibition of Matrix Metalloproteinase-8 Decreases Ventilator-induced Lung Injury
American Journal of Respiratory Cell and Molecular Biology, 12/11/09
Innate Immunity in the Therapeutic Actions of Endothelial Progenitor Cells in Pulmonary Hypertension
American Journal of Respiratory Cell and Molecular Biology, 12/11/09
Accuracy of RECIST 1.1 for non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors
Lung Cancer, 12/10/09
Today in CV/Thromboembolic...keeping you current
Receive free subspecialty "5-minute updates" via email
Innate Immunity in the Therapeutic Actions of Endothelial Progenitor Cells in Pulmonary Hypertension
American Journal of Respiratory Cell and Molecular Biology, 12/11/09
Medical and non-medical considerations for the outpatient management of children with pulmonary arterial hypertension
Progress in Pediatric Cardiology, 12/10/09
Lung transplantation for pediatric pulmonary hypertension
Progress in Pediatric Cardiology, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor